 |
|
|
| |
Resistance analyses of HCV isolates from patients treated with simeprevir in Phase IIB/III studies
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
Oliver Lenz,1 Bart Fevery,1 Thierry Verbinnen,1 Lotke Tambuyzer,1 Leen Vijgen,1 Monika Peeters,1 Maria Beumont-Mauviel,1 Gaston Picchio,2 Sandra De Meyer1
1Janssen Infectious Diseases BVBA, Beerse, Belgium; 2Janssen Research & Development, LLC, Titusville, NJ, USA
|
| |
|
|
|
|
|
